BioRender Icon

Pseudostratified epithelial cell 2 (damaged)

Pseudostratified epithelial cell 2 (damaged) - Editable icon of Pseudostratified epithelial cell 2 (damaged)
[{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37086/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37086/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37087/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37087/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37088/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37088/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37089/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37089/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708a/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708a/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708b/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708b/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708c/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708c/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708d/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708d/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708e/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708e/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3708f/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3708f/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37090/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37090/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37091/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37091/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37092/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37092/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37093/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37093/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37094/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37094/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37095/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37095/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37096/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37096/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37097/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37097/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37098/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37098/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb37099/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb37099/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709a/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709a/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709b/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709b/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709c/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709c/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709d/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709d/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709e/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709e/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb3709f/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb3709f/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a0/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a0/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a1/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a1/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a2/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a2/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a3/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a3/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a4/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a4/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a5/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a5/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a6/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a6/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a7/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a7/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a8/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a8/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370a9/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370a9/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370aa/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370aa/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ab/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ab/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ac/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ac/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ad/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ad/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370ae/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370ae/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370af/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370af/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b0/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b0/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b1/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b1/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b2/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b2/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b3/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b3/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b4/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b4/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b5/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b5/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b6/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b6/5d1e63f409f8320400b7f3cd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/66d9fc553ccf015b9bb370b7/5d1e63f409f8320400b7f3cd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/66d9fc553ccf015b9bb370b7/5d1e63f409f8320400b7f3cd.png"}]
Use This Icon – Free
No credit card required to sign up.

This icon is fully editable in BioRender

  • Add text, shapes, & other icons
  • Search 50,000+ scientifically accurate icons
  • Recolor and rearrange every icon, line, & label
  • Export or share for any use case
Scientist Avatars

Join 4M+ scientists already making publication-ready figures

Go from icons to finished figure – in minutes

  • Search from 50,000+ scientifically accurate, peer-reviewed icons
  • Customize with labels, shapes, and additional icons – everything is completely editable
  • Export or share your figures with collaborators

Not quite the right icon? Discover more.

Search 50,000+ icons across 30+ life-science fields.

search icon
arrow-right
Keywords
epithelium,columnar,epithelia,damage,atrophy,pseudostratified epithelium,pseudostratified epithelial cell
View More

Try a synonym, or sign up to request an icon from the app.

Image types

Pseudostratified epithelial cell 2 (damaged) icon JPEG

Pseudostratified epithelial cell 2 (damaged) icon PNG

Pseudostratified epithelial cell 2 (damaged) icon SVG

Pseudostratified epithelial cell 2 (damaged) icon GIF

Biorender Icon FAQs

How are scientists using the Pseudostratified epithelial cell 2 (damaged) icon in their work?

BioRender users often use the Pseudostratified epithelial cell 2 (damaged) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Pseudostratified epithelial cell 2 (damaged) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pseudostratified epithelial cell 2 (damaged) icon customizable in BioRender?

Most icons in BioRender, including the Pseudostratified epithelial cell 2 (damaged) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pseudostratified epithelial cell 2 (damaged) icon for publication or presentations?

Yes, figures containing the Pseudostratified epithelial cell 2 (damaged) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pseudostratified epithelial cell 2 (damaged) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pseudostratified epithelial cell 2 (damaged) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pseudostratified epithelial cell 2 (damaged) icon along with our library of more than 30,000 life science icons.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now
x icon